|1.||Belcaro, G: 11 articles (06/2010 - 01/2002)|
|2.||Cesarone, M R: 11 articles (06/2010 - 01/2002)|
|3.||Dugall, M: 9 articles (06/2010 - 01/2002)|
|4.||Acerbi, G: 9 articles (03/2006 - 01/2002)|
|5.||Ippolito, E: 8 articles (06/2010 - 01/2002)|
|6.||Ricci, A: 6 articles (06/2010 - 07/2002)|
|7.||Hu, Bin: 5 articles (01/2015 - 01/2009)|
|8.||Lu, Jun: 5 articles (01/2015 - 01/2009)|
|9.||Pellegrini, L: 5 articles (06/2010 - 04/2003)|
|10.||Incandela, L: 5 articles (01/2002 - 01/2002)|
06/01/2010 - "This study evaluated the clinical efficacy of Venoruton (O-(beta-hydroxyethyl)-rutosides) (HR) (Novartis Consumer Healthcare) in subjects with severe chronic venous insufficiency (CVI). "
03/01/2006 - "Circulating endothelial cells in venous blood as a marker of endothelial damage in chronic venous insufficiency: improvement with venoruton."
03/01/2005 - "The aim of this independent study was to demonstrate the rapidity of the clinical action of HR 0-(beta-hydroxyethyl)-rutosides, Venoruton (Novartis Consumer Health) in patients with chronic venous insufficiency (CVI). "
03/01/2005 - "HR, 0-(beta-hydroxyethyl)-rutosides; (Venoruton): rapid relief of signs/symptoms in chronic venous insufficiency and microangiopathy: a prospective, controlled study."
05/01/2002 - "Oxerutins (Venoruton): efficacy in chronic venous insufficiency--a double-blind, randomized, controlled study."
|2.||Hypertension (High Blood Pressure)
01/01/1989 - "In conclusion this study showed the efficacy of Venoruton in improving parameters altered in venous hypertension and the possibility of application of this microcirculatory model to study venoactive drugs used for treating venous hypertension."
01/01/1989 - "In this study we combined the microcirculatory evaluation with foot and leg volumetry to evaluate the effects of Venoruton in 15 patients with deep (popliteal vein) incompetence and venous hypertension, treated for 6 weeks. "
05/01/1989 - "A new system to evaluate capillary permeability, the vacuum suction chamber (VSC) device, was used to assess the effects of Venoruton in patients with venous hypertension. "
01/01/1989 - "Evaluation of the microcirculatory effects of Venoruton in patients with chronic venous hypertension by laserdoppler flowmetry, transcutaneous PO2 and PCO2 measurements, leg volumetry and ambulatory venous pressure measurements."
01/01/1988 - "Effects of Troxerutin on the hemorheological parameters of patients with moderate arterial hypertension."
03/01/2003 - "The aim of this independent study was to evaluate the protective effects, on the development of flight edema, of Venoruton. "
01/01/2003 - "This study evaluated the protective effects of Venoruton on the development of flight edema in normal subjects travelling in economy in long-haul flights (8-9 hours). "
04/01/2003 - "Flight microangiopathy on long-haul flights: prevention of edema and microcirculation alterations with Venoruton."
03/01/2003 - "The combined evaluation of the edema score is significantly favorable for patients treated with Venoruton. "
03/01/2003 - "Therefore, the control of flight edema with Venoruton was clear both considering parametric data (circumference and volume) and nonparametric (analogue scale lines) measurements. "
|4.||Varicose Veins (Varicose Vein)
01/01/1973 - "The effect of paroven (HR) on the clearance of sodium-24 from the subcutaneous tissues of the foot in patients with varicose veins."
03/01/2003 - "A group of 203 subjects with chronic venous disease (uncomplicated varicose veins) at low-medium risk for DVT were contacted; 43 subjects were excluded for several nonmedical, travel-related problems or inconvenient evaluation time; the remaining 160 were randomized, after informed consent, into 2 groups to evaluate 2 prophylaxes in 7-8-hour, long-haul flights: The treatment group received Venoruton (hydroxyethyl rutosides) 1 g twice daily for 3 days (2 days before the flight and the day of the flight). "
04/01/2003 - "The aim of this study was the evaluation of the effects of Venoruton (HR) on the prevention and control of flight microangiopathy and edema in subjects with varicose veins flying for more than 7 hours. "
05/01/2005 - "Prevention of edema and flight microangiopathy with Venoruton (HR), (0-[beta-hydroxyethyl]-rutosides) in patients with varicose veins."
10/01/1994 - "Studies on the effect of short-term oral dihydroergotamine and troxerutin in patients with varicose veins."
10/15/1994 - "At the end of follow-up, members of the troxerutin-treated group, as compared with the placebo group, showed significant improvement in visual acuity (P = .03), macular threshold (P = .01), retinal circulation times (P = .04), and macular edema (P = .05). "
06/01/1982 - "[Prevention of cystoid macular edema with O-beta-hydroxyethyl-rutoside (Venoruton) in a double-blind study]."
04/01/2011 - "The purpose of this study was to evaluate the orally administered combination of flavonoids desmin and troxerutin with Centella asiatica and Melilotus for the treatment of diabetic cystoid macular edema (CME) without macular thickening. "